Page last updated: 2024-08-24

dexmedetomidine and Pain, Intractable

dexmedetomidine has been researched along with Pain, Intractable in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's6 (46.15)24.3611
2020's5 (38.46)2.80

Authors

AuthorsStudies
Atayee, RS; Byrne, JM; Edmonds, KP; Mesarwi, P1
Dieudonné Rahm, N; Kemicha, T; Papasokrati, L; Pautex, S1
Atayee, RS; Chang, J; Edmonds, KP1
Alleyne, A; Schellenberg, J; Yu, SY1
Abrahm, JL; Hofherr, ML; Rickerson, E1
Wang, Q; Wu, J; Xu, M; Yuan, X1
Hato, A; Ikegaki, J; Kimura, Y; Komasawa, N1
Gao, XZ; Jin, Y; Li, WY; Liu, HJ; Liu, XM; Xia, M1
Brown, S; Hilliard, N; Mitchinson, S1
Bobb, B; Coyne, PJ; Roberts, SB; Smith, TJ; Wozencraft, CP1
Coyne, PJ; Roberts, SB; Smith, TJ; Wozencraft, CP1
Martins, MA; Naylor, C; Peixoto, G; Soares, LG1
Aoe, T; Kozikowski, A; Neale, JH; Saito, O; Sarva, J; Yamamoto, T1

Trials

1 trial(s) available for dexmedetomidine and Pain, Intractable

ArticleYear
Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain.
    Journal of palliative medicine, 2014, Volume: 17, Issue:7

    Topics: Adult; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Cross-Over Studies; Dexmedetomidine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Male; Middle Aged; Morphine; Neoplasms; Outcome Assessment, Health Care; Pain Management; Pain Measurement; Pain, Intractable

2014

Other Studies

12 other study(ies) available for dexmedetomidine and Pain, Intractable

ArticleYear
Dexmedetomidine Continuous Infusion for Refractory Cancer Pain at End of Life: A Case Report.
    Journal of pain & palliative care pharmacotherapy, 2022, Volume: 36, Issue:3

    Topics: Analgesics, Opioid; Cancer Pain; Death; Dexmedetomidine; Female; Humans; Middle Aged; Neoplasms; Pain, Intractable

2022
Long-Term Dexmedetomidine Use and Safety Profile in Palliative Care: A Case Report.
    Journal of palliative medicine, 2023, Volume: 26, Issue:6

    Topics: Adult; Cancer Pain; Dexmedetomidine; Humans; Hypnotics and Sedatives; Male; Pain, Intractable; Palliative Care

2023
A National Survey of Institutional Guidelines for the Use of Ketamine, Lidocaine, and Dexmedetomidine for Refractory Pain.
    Journal of palliative medicine, 2023, Volume: 26, Issue:7

    Topics: Analgesics, Opioid; Dexmedetomidine; Double-Blind Method; Humans; Ketamine; Lidocaine; Pain, Intractable

2023
Dexmedetomidine use for patients in palliative care with intractable pain and delirium: A retrospective study.
    PloS one, 2023, Volume: 18, Issue:9

    Topics: Adolescent; Adult; Delirium; Dexmedetomidine; Humans; Hypnotics and Sedatives; Intensive Care Units; Pain, Intractable; Palliative Care; Retrospective Studies

2023
Dexmedetomidine: A Novel Strategy for Patients with Intractable Pain, Opioid-Induced Hyperalgesia, or Delirium at the End of Life.
    Journal of palliative medicine, 2020, Volume: 23, Issue:11

    Topics: Analgesics, Opioid; Death; Delirium; Dexmedetomidine; Humans; Hyperalgesia; Hypnotics and Sedatives; Intensive Care Units; Pain, Intractable

2020
The antinociceptive effect of systemic administration of a combination of low-dose tramadol and dexmedetomidine in a rat model of bone cancer pain.
    European journal of anaesthesiology, 2014, Volume: 31, Issue:1

    Topics: Analgesics; Animals; Bone Neoplasms; Dexmedetomidine; Drug Therapy, Combination; Female; Pain, Intractable; Rats; Rats, Wistar; Tramadol

2014
[Three successful cases of continuous dexmedetomidine infusion for the treatment of intractable delirium associated with cancer pain].
    Masui. The Japanese journal of anesthesiology, 2013, Volume: 62, Issue:12

    Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Delirium; Dexmedetomidine; Fatal Outcome; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Pain, Intractable; Palliative Care; Treatment Outcome

2013
A case report of dexmedetomidine used to treat intractable pain and delirium in a tertiary palliative care unit.
    Palliative medicine, 2015, Volume: 29, Issue:3

    Topics: Analgesics, Non-Narcotic; Delirium; Dexmedetomidine; Female; Humans; Infusions, Subcutaneous; Middle Aged; Neuralgia; Pain, Intractable; Palliative Care; Uterine Cervical Neoplasms

2015
Dexmedetomidine: exploring its potential role and dosing guideline for its use in intractable pain in the palliative care setting.
    Journal of pain & palliative care pharmacotherapy, 2010, Volume: 24, Issue:4

    Topics: Analgesics, Non-Narcotic; Dexmedetomidine; Humans; Pain, Intractable; Palliative Care; Practice Guidelines as Topic

2010
Dexmedetomidine as an adjuvant analgesic for intractable cancer pain.
    Journal of palliative medicine, 2011, Volume: 14, Issue:3

    Topics: Analgesics, Non-Narcotic; Chemotherapy, Adjuvant; Dexmedetomidine; Female; Humans; Middle Aged; Neoplasms; Pain, Intractable

2011
Dexmedetomidine: a new option for intractable distress in the dying.
    Journal of pain and symptom management, 2002, Volume: 24, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Dexmedetomidine; Fatal Outcome; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Neoplasms; Pain, Intractable; Palliative Care

2002
Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer pain.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2006, Volume: 53, Issue:9

    Topics: Adrenergic alpha-Agonists; Analgesia; Animals; Bone Neoplasms; Dexmedetomidine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Ketamine; Male; Mice; Mice, Inbred C3H; Morphine; Pain, Intractable; Protease Inhibitors; Urea

2006